Grandbrothers/iStock Editorial via Getty Images
The US FDA has issued a Complete Response Letter to Outlook Therapeutics (OTLK) for its resubmitted Biologics License Application for ONS-5010/Lytenava (bevacizumab-vikg) for wet age-related macular degeneration. Shares are down ~80% in after-hours trading Wednesday. The agency said that additional information the company provided
Follow us on Google for the latest stock news
Vertiv (VRT) had one of its roughest earnings days this week. Its stock fell about 17% on July 29. The...
Tech earnings were dominated by bigwigs including Apple (AAPL), Microsoft (MSFT), and Qualcomm (QCOM) this week, keeping investors glued to...
SpaceX pulled off a successful launch last Friday evening at its Starbase facility in South Texas, sending its Starship rocket into orbit....
Quick Read MSFT surged 15% post-earnings while GOOGL slipped, after both doubled capex and GOOGL posted its first-ever negative free...
A finance employee at the global design firm Arup transferred $25.6 million in a deepfake fraud after joining a video...
It used to be, in the not-too-distant past, that the core constituencies of the Democratic Party were blacks, Hispanics, and...
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.
